Menu
Science and research

Professional Publications

Author
Title
Year of publication

Publications (3663)

[241]

McLornan, D.; Eikema, D.J.; Czerw, T.; Kröger, N.; Koster, L.; Reinhardt, H.C.; Angelucci, E.; Robin, M.; Bornhäuser, M.; Passweg, J.; Clark, A.; Vydra, J.; et al.

Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis

[year of publication 2021, impact factor 5.483 ]

[242]

Babušiak, M.; Man, P.; Petrák, J.; Vyoral, D.

Native proteomic analysis of protein complexes in murine intestinal brush border membranes

[year of publication 2007, impact factor 5.479]

[243]

Tidu, F.; De Zuani, M.; Jose, S.S.; Bendíčková, K.; Kubala, L.; Caruso, F.; Cavalieri, F.; Forte, G.; Frič, J.

NFAT signaling in human mesenchymal stromal cells affects extracellular matrix remodeling and antifungal immune responses

[year of publication 2021, impact factor 5.458 ]

[244]

Rotnáglová, E.; Tachezy, R.; Saláková, M.; Procházka, B.; Košlabová, E.; Veselá, E.; Ludvíková, V.; Hamšíková, E.; Klozar, J.

HPV involvement in tonsillar cancer: prognostic significance and clinically relevant markers

[year of publication 2011, impact factor 5.444 ]

[245]

Tonarova, P.; Lochovska, K.; Pytlik, R.; Hubalek Kalbacova, M.

The impact of various culture conditions on human mesenchymal stromal cells metabolism

[year of publication 2021, impact factor 5.443 ]

[246]

Akan, H.; Antia, V.P.; Kouba, M.; Sinkó, J.; Tanase, A.D.; Vrhovac, R.; Herbrecht, R.

Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects

[year of publication 2013, impact factor 5.439 ]

[247]

Štach, M.; Ptáčková, P.; Mucha, M.; Musil, J.; Klener, P.; Otáhal, P.

Inducible secretion of IL-21 augments anti-tumor activity of piggyBac-manufactured chimeric antigen receptor T cells

[year of publication 2020, impact factor 5.414 ]

[248]

Rector, A.; Tachezy, R.; Van Ranst, M.

A sequence-independent strategy for detection and cloning of circular DNA virus genomes by using multiply primed rolling-circle amplification

[year of publication 2006, impact factor 5.398]

[249]

Hortová Kohoutková, M.; Lázničková, P.; Bendíčková, K.; De Zuani, M.; Andrejčinová, I.; Tomášková, V.; Suk, P.; Šrámek, V.; Helán, M.; Frič, J.

Differences in monocyte subsets are associated with short-term survival in patients with septic shock

[year of publication 2020, impact factor 5.310 ]

[250]

Sroller, V.; Vilchez, R.A.; Stewart, A.R.; Wong, C.; Butel, J.S.

Influence of the viral regulatory region on tumor induction by simian virus 40 in hamsters

[year of publication 2008, impact factor 5.308]

[251]

Cmejlova, J.; Hildinger, M.; Cmejla, R.; Fuchs, O.; Zakova, D.; Baum, C.; Jelinek, J.

Impact of splice-site mutations of the human MDR1 cDNA on its stability and expression following retroviral gene transfer

[year of publication 2006, impact factor 5.293]

[252]

Morfin, F.; Dupuis-Girod, S.; Mundweiler, S.; Falcon, D.; Carrington, D.; Sedlacek, P.; Bierings, M.; Cetkovsky, P.; Kroes, A.C.; van Tol, M.J.; Thouvenot, D.:

In vitro susceptibility of adenovirus to antiviral drugs is species-dependent.

[year of publication 2006, impact factor 5.286]

[253]

Weinbergerová, B.; Demel, I.; Víšek, B.; Válka, J.; Čerňan, M.; Jindra, P.; Novák, J.; Stejskal, L.; Kovácsová, F.; Kabut, T.; Szotkowski, T.; Hájek, R.; Žák, P.; Cetkovský, P.; Král, Z.; Mayer, J.

Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience

[year of publication 2022, impact factor 5.271 ]

[254]

Maly, M.; Riedel, T.; Stikarova, J.; Suttnar, J.; Kotlin, R.; Hajsl, M.; Tousek, P.; Kaufmanova, J.; Kucerka, O.; Weisel, J.W.; Dyr, J.E.

Incorporation of fibrin, platelets, and red blood cells into a coronary thrombus in time and space

[year of publication 2021, impact factor 5.249 ]

[255]

Jelinek, J.; Rafferty, J.A.; Cmejla, R.; Hildinger, M.; Chinnasamy, D.; Lashford, L.S.; Ostertag, W.; Margison, G.P.; Dexter, T.M.; Fairbairn, L.J.; Baum, C.

A novel dual function retrovirus expressing multidrug resistance 1 and 06-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents

[year of publication 2006, impact factor 5.237]

[256]

Wohlfahrtova, M.; Hruba, P.; Klema, J.; Novotny, M.; Krejcik, Z.; Stranecky, V.; Honsova, E.; Vichova, P.; Viklicky, O.

Early isolated V-lesion may not truly represent rejection of the kidney allograft

[year of publication 2018, impact factor 5.237 ]

[257]

Cerny, J.; Slavickova, A.; Krepelova, A.; Trneny, M.; Karban, J.; Klener, P.

Biallelic IgH rearragements in patients with indolent lymphoproliferative disorders : molecular and practical implications

[year of publication 2006, impact factor 5.222]

[258]

Chiaretti, S.; Messina, M.; Grammatico, S.; Piciocchi, A.; Fedullo, A.L.; Di Giacomo, F.; Peragine, N.; Gianfelici, V.; Lauretti, A.; Bareja, R.; Martelli, M.P.; Vignetti, M.; Apicella, V.; Vitale, A.; Li, L.S.; Salek, C.; et al.

Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications

[year of publication 2018, impact factor 5.206 ]

[259]

McLornan, D.P.; Szydlo, R.; Robin, M.; van Biezen, A.; Koster, L.; Blok, H.J.P.; Van Lint, M.T.; Finke, J.; Vitek, A.; et al.

Outcome of patients with myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

[year of publication 2018, impact factor 5.206 ]

[260]

Soverini, S.; De Benedittis, C.; Machova Polakova, K.; Linhartova, J.; Castagnetti, F.; Gugliotta, G.; Papayannidis, C.; Mancini, M.; Klamova, H.; Salvucci, M.; Crugnola, M.; Iurlo, A.; Albano, F.; Russo, D.; Rosti, G.; Cavo, M.; Baccarani, M.; Martinelli, G.

Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients

[year of publication 2016, impact factor 5.168 ]


Quick contact

Head of Science and Research Division
Tel:+420 221 977 305

Deputy head of Science and Research Division
Tel:+420 221 977 648

Secretary
Tel:+420 221 977 144


Opening hours

Ambulance
Mo – Fr: 7:00–18:00
Weekends: 9:00–13:00

Donors
Mo – Fr: 7:00–10:30

Visitors
Inpatient department
Mo – Fr: 13:00–18:00

ICU and Transplant unit
Mo – Fr: 14:00–17:00

How to find us

map

Ústav hematologie a krevní transfuze
(​Institute of Hematology and Blood Transfusion)

U Nemocnice 2094/1
128 00 Praha 2

The nearest underground station: Karlovo náměstí (line B)

The nearest tram station: Karlovo náměstí (10, 16, 22), Moráň (3, 6, 10, 16, 18, 24)

The nearest bus station: U Nemocnice (148), Karlovo náměstí (176)

How to get here